Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bolten

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Treatment Reviews|December 18, 2007
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendationsR E Coleman, W W Bolten, M Lansdown, et al.
Deutsche Medizinische Wochenschrift (1946)|February 5, 1988
[Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients]E M Lemmel, G L Bach, W Bolten, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activityJessica D Dietz, Sarah Du, Charles W Bolten, et al.
British Journal of Rheumatology|June 1, 1995
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trialG Wylie, T Appelboom, W Bolten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapyP Hadji, C Jackisch, W Bolten, et al.
The Journal of Rheumatology|February 1, 1997
Efficacy and safety of meloxicam in patients with rheumatoid arthritisE M Lemmel, W Bolten, R Burgos-Vargas, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|March 9, 1999
HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestationsC Seidl, U R Kässer, B Fischer, et al.
Diabetes & Vascular Disease Research|July 27, 2007
Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive ratCharles W Bolten, Maria A Payne, William G McDonald, et al.
Gene Regulation and Systems Biology|November 26, 2009
Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gammaCharles W Bolten, Patrick M Blanner, William G McDonald, et al.
Zeitschrift Fur Gastroenterologie|August 12, 2016
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]W Fischbach, P Malfertheiner, P Lynen Jansen, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reviews|December 18, 2007
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendationsR E Coleman, W W Bolten, M Lansdown, et al.
Deutsche Medizinische Wochenschrift (1946)|February 5, 1988
[Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients]E M Lemmel, G L Bach, W Bolten, et al.
Hypertension (Dallas, Tex. : 1979)|February 6, 2008
A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activityJessica D Dietz, Sarah Du, Charles W Bolten, et al.
British Journal of Rheumatology|June 1, 1995
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: a 24-week analysis of a 1-year clinical trialG Wylie, T Appelboom, W Bolten, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapyP Hadji, C Jackisch, W Bolten, et al.
The Journal of Rheumatology|February 1, 1997
Efficacy and safety of meloxicam in patients with rheumatoid arthritisE M Lemmel, W Bolten, R Burgos-Vargas, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|March 9, 1999
HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestationsC Seidl, U R Kässer, B Fischer, et al.
Diabetes & Vascular Disease Research|July 27, 2007
Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive ratCharles W Bolten, Maria A Payne, William G McDonald, et al.
Gene Regulation and Systems Biology|November 26, 2009
Insulin sensitizing pharmacology of thiazolidinediones correlates with mitochondrial gene expression rather than activation of PPAR gammaCharles W Bolten, Patrick M Blanner, William G McDonald, et al.
Zeitschrift Fur Gastroenterologie|August 12, 2016
[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]W Fischbach, P Malfertheiner, P Lynen Jansen, et al.
Pageof 7